(Q34970844)

5 August 2017

title

Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers (English)

1 reference

5 August 2017

0 references

Edward L. Giovannucci

series ordinal

object named as

Edward Giovannucci

1 reference

5 August 2017

Jeffrey A Meyerhardt

1 reference

5 August 2017

Charles S Fuchs

1 reference

5 August 2017

Katsuhiko Nosho

1 reference

5 August 2017

Shuji Ogino

1 reference

5 August 2017

Yoshifumi Baba

1 reference

5 August 2017

Kaori Shima

1 reference

5 August 2017

Marika Hayashi

series ordinal

1 reference

5 August 2017

Andrew T Chan

series ordinal

1 reference

5 August 2017

language of work or name

English

0 references

publication date

8 November 2010

1 reference

5 August 2017

1 reference

5 August 2017

volume

117

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

1399-1408

1 reference

Do pressures to publish increase scientists' bias? An empirical support from US States Data

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

The PI3K pathway as drug target in human cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Novel agents on the horizon for cancer therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

PI3K/Akt: getting it right matters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Cohort study of fatty acid synthase expression and patient survival in colon cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Cotargeting survival signaling pathways in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

The potential role of Akt phosphorylation in human cancers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Predictive markers in breast cancer--the present

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Molecular classification and correlates in colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

AKT/PKB signaling: navigating downstream

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

A knotty turnabout?: Akt1 as a metastasis suppressor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Systematic review of microsatellite instability and colorectal cancer prognosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092033

Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology

8 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Prognostic significance of activated AKT expression in soft-tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Akt expression may predict favorable prognosis in cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Gene expression signature for recurrence in stage III colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Prognostic impact of extracellular matrix metalloprotease inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component

21 January 2018

1 reference

12 December 2020

Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal–regulated kinase, and phosphorylated AKT in colorectal cancer—A tissue microarray–based approach?

1 reference

12 December 2020

Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations

1 reference

12 December 2020

PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

1 reference

12 December 2020

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer

1 reference

12 December 2020

Cotargeting survival signaling pathways in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25630

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CNCR.25630

1 reference

5 August 2017

1 reference

5 August 2017

1 reference